News

  To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac (www.adaptvac.com) and Bavarian Nordic (OMX: BAVA, OTC: BVNRY). …

  VarCT Diagnostics has received a EUR 2M R&D grant from the Danish Innovation Foundation to advance Early Diagnosis of Cancer by Sensitive Detection of Circulating Tumor Cells (prEDICT).   VarCT Diagnostics ApS Ole Maaløes Vej 3 DK-2200 Copenhagen N CVR: 38733567 T: +45 78 70 19 00 info@varctdiagnostics.com

  The detection and molecular analysis of circulating tumor cells (CTCs) is an emerging strategy for early diagnosis and monitoring of cancer disease. However, the isolation of rare CTCs from blood samples requires highly sensitive capture methods. Our novel study published in the International Journal of Molecular Sciences gives insight …